Cisco on Deck: What...
Health Care: Drugs
Genta Inc. (GNTA: OTC)
$0.00 0.00 | 5.00%
02/08/12 - 01:08 PM ET
7.20M / 56.68M
Vol / Avg. Vol:0.00 / 0.00
Open / Prev. Close:0.00 - 0.00
Today's Range:0.00 - 0.50
52 Wk Range:-23.08%
Performance YTD:TheStreet Rating:
Portfolios with GNTA
- Portfolio NameUser Type
- UserBAKER
- UserNest Egg
- Userpres-picks
- UserFinallyforus
- Usermontyguitar's portfolio
- Usersmallbiz
- Usertkconsult Portfolio 1
- UserMy Stock Pick
- Userunixx
- UserStoli Portfolio 1
Latest GNTA Headlines from TheStreet
- Genta Incorporated Reports Fourth Quarter And 2010 Year-End Financial Results And Updates Key Product And Corporate Developments 03.30.11 | 07:03 am
- Genta Incorporated To Host Conference Call To Discuss Fourth Quarter 2010 Highlights And Financial Results (Webcast) 03.24.11 | 09:03 am
- Stock Symbol For Genta Incorporated Reverts To GNTA.OB 03.21.11 | 11:03 am
- Board Of Directors Of Genta Incorporated Announces Reverse Split Of Company's Common Stock 02.17.11 | 04:02 pm
- Genta Initiates Trial With Tesetaxel As First- And Second-Line Chemotherapy For Patients With Advanced Prostate Cancer 02.10.11 | 08:02 am
- Genta Incorporated To Present At The 13th Annual BIO CEO & Investor Conference 02.07.11 | 08:02 am
- Genta Appoints Ana I. Stancic And Dr. Marvin E. Jaffe To Board Of Directors 01.20.11 | 08:01 am
- Feuerstein's Biotech-Stock Mailbag 04.05.08 | 11:04 am
- Tuesday's Health Winners & Losers 08.21.07 | 04:08 pm
- Run for the Record Books 12.15.06 | 05:12 pm
Press Releases for GNTA
- Genta Provides Comprehensive Update Of Research And Development Activities - Business Wire 01.11.11 | 08:01 am
- Genta Incorporated To Present At The Biotech Showcase--2011 Conference - Business Wire 01.05.11 | 08:01 am
- Genta Completes $5 Million Financing - Business Wire 12.15.10 | 08:12 am
- Genta Incorporated Reports Third Quarter 2010 Corporate Highlights And Financial Results - Business Wire 11.11.10 | 07:11 am
- LifeSci Advisors Announces Investment Opinion On Genta Incorporated - Business Wire 11.09.10 | 01:11 pm
- Genta Initiates Trial With Tesetaxel As First-Line Chemotherapy For Women With Metastatic Breast Cancer - Business Wire 11.08.10 | 08:11 am
- Genta Incorporated To Host Conference Call To Discuss Third Quarter 2010 Highlights And Financial Results - Business Wire 11.04.10 | 08:11 am
- Genta Awarded Two Federal Grants Totaling $488,958 For Qualifying Therapeutic Discovery Projects - Business Wire 11.02.10 | 08:11 am
- Genta Receives Scientific Advice From European Medicines Agency Supporting Randomized Phase 3 Trial Of Tesetaxel In Patients With Advanced Gastric Cancer - Business Wire 11.01.10 | 08:11 am
- Stock Symbol For Genta Incorporated Reverts To GNTA.OB - Business Wire 10.18.10 | 08:10 am
Partner Headlines for GNTA
- Genta Reports the Number of Outstanding Shares at 1,062,664,725 as of December 16, 2011 - Benzinga 12.16.11 | 06:12 pm
